Completed NA INTERVENTIONAL 2-arm NCT04518579

Epidural-inhalational Versus Epidural-intravenous Anaesthesia on Anti-tumor Immunity in Patients With Cancer Colon (tumorimmunity)

Effect of Epidural-inhalational Versus Epidural-intravenous Anaesthesia on Anti-tumor Immunity in Patients Undergoing Open Surgery for Cancer Colon

Sponsor: South Egypt Cancer Institute

Conditions Immunity Factors in Cancer Colon Patients

Interventions thoracic epidural

Updated 5 times since 2020 Last updated: Aug 19, 2020 Started: Apr 15, 2018 Primary completion: Jun 1, 2020 Completion: Aug 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Immunity Factors in Cancer Colon Patients and is currently completed. South Egypt Cancer Institute leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

First recorded

Apr 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

South Egypt Cancer Institute

Data source: South Egypt Cancer Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt